JENNIFER RUCH: Open Payments
NPI 1336626209 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,390 in 117 payments from 15 companies in 2025. Trend: 2023 $2,170 · 2024 $1,550 · 2025 $2,390
Food & beverage: $2,330Education: $60
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 18 | $569 |
| AstraZeneca Pharmaceuticals LP | 16 | $533 |
| Genentech USA, Inc. | 13 | $313 |
| GlaxoSmithKline, LLC. | 29 | $258 |
| ARS Pharmaceuticals Operations, Inc. | 19 | $173 |
| ABBVIE INC. | 6 | $166 |
| Incyte Corporation | 4 | $76 |
| CSL Behring | 2 | $55 |
| SANOFI-AVENTIS U.S. LLC | 1 | $53 |
| GENZYME CORPORATION | 2 | $47 |
Products named: DUPIXENT, Xolair, TEZSPIRE, NUCALA, NEFFY, RINVOQ, AIRSUPRA, FASENRA.
Industry payments across CA — which companies pay providers there.
